Poop transplant trial aims to jumpstart cancer treatment
NCT ID NCT04729322
Summary
This study is testing if a fecal microbiota transplant (FMT) can help immunotherapy drugs work for people with advanced colorectal cancer who previously did not respond to them. The FMT uses processed stool from patients who did respond to the treatment, with the goal of changing the gut bacteria to help the patient's own immune system fight the cancer. About 15 participants will receive the transplant and then restart immunotherapy to see if their cancer responds this time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.